Literature DB >> 24389211

The role of PGRN in musculoskeletal development and disease.

Jessica Konopka1, Brendon Richbourgh2, Chuanju Liu2.   

Abstract

Progranulin (PGRN) is a growth factor that has been implicated in wound healing, inflammation, infection, tumorigenesis, and is most known for its neuroprotective and proliferative properties in neurodegenerative disease. This pleiotropic growth factor has been found to be a key player and regulator of a diverse spectrum of multi-systemic functions. Its critical anti-inflammatory role in rheumatoid arthritis and other inflammatory disease models has allowed for the propulsion of research to establish its significance in musculoskeletal diseases, including inflammatory conditions involving bone and cartilage pathology. In this review, we aim to elaborate on the emerging role of PGRN in the musculoskeletal system, reviewing its particular mechanisms described in various musculoskeletal diseases, with special focus on osteoarthritis and inflammatory joint disease patho-mechanisms and potential therapeutic applications of PGRN and its derivatives in these and other musculoskeletal diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389211      PMCID: PMC4412357          DOI: 10.2741/4234

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  82 in total

1.  Progranulin and cholangiocarcinoma: another bad boy on the block!

Authors:  Domenico Alvaro
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

2.  TDP-43 frontotemporal lobar degeneration and autoimmune disease.

Authors:  Zachary A Miller; Katherine P Rankin; Neill R Graff-Radford; Leonel T Takada; Virginia E Sturm; Clare M Cleveland; Lindsey A Criswell; Philipp A Jaeger; Trisha Stan; Kristin A Heggeli; Sandy Chan Hsu; Anna Karydas; Baber K Khan; Lea T Grinberg; Maria Luisa Gorno-Tempini; Adam L Boxer; Howard J Rosen; Joel H Kramer; Giovanni Coppola; Daniel H Geschwind; Rosa Rademakers; William W Seeley; Tony Wyss-Coray; Bruce L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-30       Impact factor: 10.154

3.  The hairpin stack fold, a novel protein architecture for a new family of protein growth factors.

Authors:  R Hrabal; Z Chen; S James; H P Bennett; F Ni
Journal:  Nat Struct Biol       Date:  1996-09

4.  Modified yeast-two-hybrid system to identify proteins interacting with the growth factor progranulin.

Authors:  Qing-Yun Tian; Yun-Peng Zhao; Chuan-ju Liu
Journal:  J Vis Exp       Date:  2012-01-17       Impact factor: 1.355

Review 5.  The role of TNF in cardiovascular disease.

Authors:  R Ferrari
Journal:  Pharmacol Res       Date:  1999-08       Impact factor: 7.658

6.  Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin.

Authors:  Kai Kessenbrock; Leopold Fröhlich; Michael Sixt; Tim Lämmermann; Heiko Pfister; Andrew Bateman; Azzaq Belaaouaj; Johannes Ring; Markus Ollert; Reinhard Fässler; Dieter E Jenne
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

7.  PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells.

Authors:  Wisit Tangkeangsirisin; Ginette Serrero
Journal:  Carcinogenesis       Date:  2004-04-29       Impact factor: 4.944

Review 8.  Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Authors:  Zhiheng He; Andrew Bateman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

9.  Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis.

Authors:  Virginia Martínez-Santana; E González-Sarmiento; Ma Calleja-Hernández; T Sánchez-Sánchez
Journal:  Patient Prefer Adherence       Date:  2013-07-29       Impact factor: 2.711

10.  Prevention of LPS-induced acute lung injury in mice by progranulin.

Authors:  Zhongliang Guo; Qinchuan Li; Yang Han; Yongjie Liang; Zengguang Xu; Tao Ren
Journal:  Mediators Inflamm       Date:  2012-08-15       Impact factor: 4.711

View more
  7 in total

Review 1.  Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases.

Authors:  Yazhou Cui; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2019-01-30       Impact factor: 7.638

2.  Foxo4- and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.

Authors:  Wenyu Fu; Wenhuo Hu; Lei Shi; Jyoti Joshi Mundra; GuoZhi Xiao; Michael L Dustin; Chuan-Ju Liu
Journal:  FASEB J       Date:  2016-12-23       Impact factor: 5.191

3.  Injectable recombinant block polymer gel for sustained delivery of therapeutic protein in post traumatic osteoarthritis.

Authors:  Priya Katyal; Aubryanna Hettinghouse; Michael Meleties; Sadaf Hasan; Changhong Chen; Min Cui; Guodong Sun; Rajiv Menon; Bonnie Lin; Ravinder Regatte; Jin Kim Montclare; Chuan-Ju Liu
Journal:  Biomaterials       Date:  2022-01-10       Impact factor: 15.304

Review 4.  The Function and Roles of ADAMTS-7 in Inflammatory Diseases.

Authors:  Yuying Zhang; Jiqiang Lin; Fanhua Wei
Journal:  Mediators Inflamm       Date:  2015-11-30       Impact factor: 4.711

5.  MiR-29b-3p promotes chondrocyte apoptosis and facilitates the occurrence and development of osteoarthritis by targeting PGRN.

Authors:  Lingqiang Chen; Qin Li; Jing Wang; Song Jin; Hongmei Zheng; Jun Lin; Fang He; Hong Zhang; Sha Ma; Jian Mei; Juan Yu
Journal:  J Cell Mol Med       Date:  2017-06-13       Impact factor: 5.310

6.  Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice.

Authors:  Maki Murakoshi; Tomohito Gohda; Eri Adachi; Saki Ichikawa; Shinji Hagiwara; Yusuke Suzuki
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 7.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.